Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals

Clinical trial NCT04681430 · COMPLETED

Trial details

NCT number: NCT04681430
Sponsor: Heinrich-Heine University, Duesseldorf
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Corona Virus Infection SARS-CoV-2 Infection SARS-CoV-2 PCR Test Positive SARS-CoV-2 Acute Respiratory Disease

Start date: 2021-01-08
Primary completion: 2021-10-29
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.